Auto-generated from public data. Not the firm's stated position.
Chalmers Ventures AB appears to focus on early-stage deep tech companies, with recent portfolio activity suggesting an emphasis on AI-driven solutions and advanced healthcare diagnostics. Based on disclosed data, the firm typically deploys check sizes between €0.1M and €1.5M into Series A and Series B stage companies across biotech and software optimization sectors.
Generated 1 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-extracted from press releases.
Focus and check size from the firm's website. Website reachable as of Oct 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.